A lot of Wall Street pundits have been advising their audience to short the QQQ. I wanted to see if there were any gems among the rocks so I used Barchart to sort the NASDAQ 100 Index stocks for the highest technical buy signals.

Vertex Pharmaceuticals Incorporated (VRTX) was a big mover last session, as its shares rose almost 7% on the day.

Except for one gas utility fund (GASFX), only Health Care mutual funds outperformed the S&P 500 over multiple long and short periods (including 2008) with “reasonable” volatility for return generated.

September E-mini S&Ps (ESU14 -0.16%) this morning are down -0.14% and European stocks are down -0.40% on concern the economic recovery is slowing in Europe after German May exports fell more than expected and after UK manufacturing unexpectedly contracted by the most in 16 months.

Isolated dividend growth backtested to 1999 shows 150% growth, McHeffey explained. This compares to a 119% in dividends, and a 50% rise in the stock prices of the index. You probably will not have to construct this portfolio by yourself as there will be an ETF soon, I believe.

Vertex soars 40% on its combination drug for Cystic Fibrosis.